Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2007-08-14
2007-08-14
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120, C435S069100, C435S320100, C435S325000, C530S388300, C530S350000, C536S023720
Reexamination Certificate
active
10354606
ABSTRACT:
The present invention relates to the use of novel nucleotide sequences for the M and N region peptide of the ferret coronavirus and derivative products for the diagnosis and treatment of epizootic catarrhal enteritis (ECE) in ferrets.
REFERENCES:
patent: 4366241 (1982-12-01), Tom et al.
patent: 4435504 (1984-03-01), Zuk et al.
patent: 4657760 (1987-04-01), Kung et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4946778 (1990-08-01), Lander et al.
patent: 4965188 (1990-10-01), Mullis et al.
patent: 5096815 (1992-03-01), Lander et al.
patent: 5198346 (1993-03-01), Lander et al.
patent: 5206344 (1993-04-01), Katre et al.
patent: 5223409 (1993-06-01), Lander et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5474796 (1995-12-01), Brennan
patent: 5538848 (1996-07-01), Livak et al.
patent: 5584807 (1996-12-01), McCabe
patent: 5656275 (1997-08-01), Wasmoen et al.
patent: 5780266 (1998-07-01), Dale et al.
patent: 6747137 (2004-06-01), Weinstock et al.
patent: 6812339 (2004-11-01), Venter et al.
patent: 1033405 (2000-09-01), None
patent: WO 90/08832 (1990-08-01), None
patent: WO 93/03176 (1993-02-01), None
patent: WO 93/03367 (1993-02-01), None
patent: WO 99/67641 (1999-12-01), None
patent: WO 00/39587 (2000-07-01), None
patent: WO 200171042 (2001-09-01), None
The Sanger Center et al., “Toward a Complete Human Genome Sequence,” Genome Research, pp. 1097-1108 (1998).
Mcgoldrick et al., “Characterisation of a recent virulent transmissible gastroenteritis virus from Britain with a deleted ORF 3a,” Arch Virol 144. pp. 763-770 (1999).
Results 1, 11, 16.rge; Results 4-7, 10-12, 16.rng; Result 1, 16.rni.
Ben-Bassat et al.,“Processing of the Initiation methionine from proteins: properties ofEscherichia colimethionine aminopeptidase and its gene structure,”J. Bacteriol.,169:751-757 (1987).
Bradley et al. “Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines,”Nature309:255-256 (1984).
Brinster et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs,”Proc. Natl. Acad. Sci. USA82:4438-4442 (1985).
Caldwell and Joyce, “Radomization of genes by PCR mutagenesis,”PCR Methods Appl.,2:28-33 (1992).
Caruthers et al.,“New Chemical Methods for Synthesizing Polynucleotides”Nucl. Acids Res.,7:215-223 (1980).
Chamberlain et al.,“New RNA polymerase fromEscherichia coliinfected with bacteriophage T7,”Nature,228:227-231 (1970).
Chow et al.,“Synthesis of oligodeoxyribonucleotides on silica gel support,”Nucl. Acids Res.9:2807-2817 (1981).
Cole et al. (1985) inMonoclonal Antibodies and Cancer Therapy,“The EBV-hybridoma techique and its application to human lung cancer,” Alan R. Liss, Inc., pp. 77-96.
Cote et al.,“Generation of human monoclonal antibodies reactive with cellular antigens,”Proc. Natl. Acad. Sci. USA,80:2026-2030 (1983).
Crameri et al., “Improved green fluorescent protein by molecular evolution using DNA shuffling,”Nat. Biotech.,12:315-319 (1996).
Crameri et al.,“Molecular evolution of an arsenate detoxification pathway by DNA shuffling,”Nat. Biotech.,15:436-438 (1997).
Crea and Horn,“Synthesis of oligonucleotides on cellulose by a phosphotriester method,”Nucl. Acids Res.,9:2331-2348 (1980).
Cwirla et al., “Peptides on phage: a vast library of peptides for indentifying ligands,” Proc. Natl. Acad. Sci. USA,87:6378-6382 (1990).
Dafforn et al.,“Rapid,simple, and reliable doctor's office test for antibodies of human immunodeficiency virus I in serum,”Clin. Chem.36:1312-1316 (1990).
Devlin et al., “Random peptide libraries: a source of specific protein binding molecules,”Science249:404-406 (1990).
deWet et al.,“Firefly luciferase gene: structure and expression in mammalian cells,”Mol. Cell. Biol.7:725-737 (1987).
Eckert and Kunkel,“DNA polymerase fidelity and the polymerase chain reaction,”PCR MethodsApp., 1:17-24 (1991).
Evans and Kaufman, “Establishment in culture of pluripotential cells from mouse embryos”Nature292:154-156 (1981).
Evans et al.,“An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies,”Nature339:385-388 (1989).
Gleba et al.,“Use of plant roots for phytoremediation and molecular farming,”Proc. Natl. Acad. Sci. U.S.A,.96:5973-5977 (1999).
Gluzman,“SV40-transformed simian cells support the replication of early SV40 mutants,”Cell23:175-182 (1981).
Gossler et al., “Transgenesis by means of blastocyst-derived embryonic stem cell lines,”Proc. Acad. Sci. USA,83:9065-9069 (1986).
Kiupel Matti
Maes Roger K.
Wise Annabel G.
Campell Bruce R.
Medlen & Carroll LLP
Salvoza M. Franco
The Board of Trustees Operating Michigan State University
LandOfFree
Compositions for the diagnosis and treatment of epizootic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for the diagnosis and treatment of epizootic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for the diagnosis and treatment of epizootic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3852832